STARLAB is a liquid handling specialist whose success is founded on the manufacture of high quality laboratory consumables. Caltech, the UKAS-accredited pipette calibration service of STARLAB UK, can service and calibrate all brands and types of pipette. We offer a range of servicing levels as well as custom servicing to your exact requirements, both in-house and at customer sites. Our expertise in all areas of liquid handling allows customers to focus their efforts on their research, with the peace of mind that the instruments and consumables they are using will perform to the highest standards.
Start Codon leverages the unique resources of the Cambridge Cluster to identify, seed-fund and drive the success of truly disruptive healthcare start-ups.
STEMCELL Technologies is a leader in the development of specialty cell culture media, cell separation products and accessory reagents for life science research. Driven by science and a passion for quality, STEMCELL delivers over 1500 products to more than 70 countries worldwide. To learn more, visit www.stemcell.com.
Stevenage Bioscience Catalyst is the UK’s first open innovation bioscience campus, pioneering a unique culture to drive early stage bioscience technology and company development. It is backed by £38m of funding from GlaxoSmithKline, the Wellcome Trust and the UK Government. Consisting of an incubator, an accelerator and a hub, covering 60,000 sq ft of laboratory, office and networking space, the independent facility houses a range of companies. Located on the GlaxoSmithKline Stevenage site, Stevenage Bioscience Catalyst is in the unique position of operating in proximity to the expertise and resources of a major pharmaceutical company, close to London and Cambridge.
Targeting pathways that modify RNA to deliver novel cancer therapeutics
Sulantrix is a small molecule drug discovery company focused on new therapies to combat specific untreatable or drug resistant cancers
I am a biotech & healthcare business strategist focussed on both talent and patients, with specialist expertise in gaining technology access and commissioning.
Sygnature Discovery, founded in 2004 in Nottingham, UK, is a leading independent provider of integrated drug discovery and pre-clinical resource and expertise. We undertake target validation, hit identification, hit-to-lead and lead optimisation projects and complete drug discovery programs. We offer fully integrated discovery project support, as well as discipline specific support in chemistry, computational sciences, in vitro biology, DMPK or in vivo pharmacology as needed by our collaborating clients. Sygnature adds significant value to collaborations by providing advanced scientific knowledge and intellectual input to accelerate clients’ drug discovery projects from target validation and lead optimisation through to pre-clinical candidate. Since 2011, 31 compounds discovered by Sygnature for clients have entered pre-clinical development and so far, 15 of these have progressed to clinical trials (Phases I, II and III). A multi award-winning company, Sygnature operates fully enabled research facilities in Nottingham and Alderley Park, UK, housing the most technologically advanced laboratories and teams of expert scientists (>80% with PhDs). For additional information, go to: www.sygnaturediscovery.com